Autor: |
Wonhee Cho, Jeongjin Park, Jinhee Kim, Minhee Lee, So Jung Park, Kyung Seok Kim, Woojin Jun, Ok-Kyung Kim, Jeongmin Lee |
Jazyk: |
angličtina |
Rok vydání: |
2023 |
Předmět: |
|
Zdroj: |
Marine Drugs, Vol 21, Iss 12, p 608 (2023) |
Druh dokumentu: |
article |
ISSN: |
1660-3397 |
DOI: |
10.3390/md21120608 |
Popis: |
The objective of this study was to investigate the effect of low-molecular-weight fish collagen (valine-glycine-proline-hydroxyproline-glycine-proline-alanine-glycine; LMWCP) on H2O2- or LPS-treated primary chondrocytes and monoiodoacetate (MIA)-induced osteoarthritis rat models. Our findings indicated that LMWCP treatment exhibited protective effects by preventing chondrocyte death and reducing matrix degradation in both H2O2-treated primary chondrocytes and cartilage tissue from MIA-induced osteoarthritis rats. This was achieved by increasing the levels of aggrecan, collagen type I, collagen type II, TIMP-1, and TIMP-3, while simultaneously decreasing catabolic factors such as phosphorylation of Smad, MMP-3, and MMP-13. Additionally, LMWCP treatment effectively suppressed the activation of inflammation and apoptosis pathways in both LPS-treated primary chondrocytes and cartilage tissue from MIA-induced osteoarthritis rats. These results suggest that LMWCP supplementation ameliorates the progression of osteoarthritis through its direct impact on inflammation and apoptosis in chondrocytes. |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|